Non-depleting reformation of immunosuppressive myeloid cells to broaden the application of anti-PD therapy-Reference-Cited by-同舟云学术

Non-depleting reformation of immunosuppressive myeloid cells to broaden the application of anti-PD therapy

Published:2021 Issue:8 Volume:13 Page:4420-4431
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Peng Si-Yuan¹²³⁴⁵,Chen Lei⁶⁷³⁸⁵,Deng Rong-Hui¹²³⁴⁵,Li Hao⁶⁷³⁸⁵,Liu Xin-Hua¹²³⁴⁵,Zheng Di-Wei¹²³⁴⁵,Wu Cong-Cong⁶⁷³⁸⁵,Liu Chuan-Jun¹²³⁴⁵^ORCID,Sun Zhi-Jun⁶⁷³⁸⁵,Zhang Xian-Zheng¹²³⁴⁵^ORCID

Affiliation:

1. Key Laboratory of Biomedical Polymers of Ministry of Education

2. Department of Chemistry

3. Wuhan University

4. Wuhan 430072

5. P. R. China

6. The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine of Ministry of Education

7. School and Hospital of Stomatology

8. Wuhan 430079

Abstract

Traditional methods of depleting tumor-associated myeloid cells via chemotherapy can easily lead to the re-recruitment of them, eventually resulting in chemo-resistance and presenting obstacles in immunotherapy.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2021/NR/D1NR00830G

Reference62 articles.

1. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

2. Cancer Evolution during Immunotherapy

3. Evolution of end points for cancer immunotherapy trials